All results
1 results for randomized double blind controlled parallel group study evaluate efficacy and safety
-
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)
This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing…
- Ages
- 18 Years - N/A
- Sexes
- All